Clinical Trials

Showing trials with last updates posted in 2020.

NCT01190410 | COMPLETED | PHASE2
16 Participants

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-08-31
Completion: 2017-11-27
Conditions
Crohn's Disease
Interventions
DRUG
NCT01168128 | COMPLETED | NA
278 Participants

PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-09-16
Completion: 2011-09-30
Conditions
Critically Ill Intensive Care Unit
Interventions
OTHER
No Results Yet
NCT01163981 | COMPLETED | NA
31 Participants

Ultrasound Guided Cannulation of Dialysis Fistulas

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2016-11-30
Completion: 2017-05-31
Conditions
Haemodialysis
Interventions
OTHER
No Results Yet
NCT01159249 | COMPLETED | PHASE3
245 Participants

Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-06-30
Completion: 2012-01-31
Conditions
Type 2 Diabetes
Interventions
DRUG
No Results Yet
NCT01148940 | TERMINATED
34 Participants

Sickle Cell Trait and the Risk of Venous Thromboembolism

Study Type: OBSERVATIONAL
Last Updated: 2020-12-17
Start Date: 2010-07-31
Completion: 2011-06-30
Conditions
Thrombosis
NCT01147003 | COMPLETED | PHASE2
93 Participants

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-06-30
Completion: 2011-09-30
Conditions
Partial Onset Seizures
Interventions
DRUG
No Results Yet
NCT01146522 | COMPLETED | PHASE1/PHASE2
8 Participants

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-05-31
Completion: 2011-10-31
Conditions
Hyperlipoproteinemia
Interventions
DRUG
No Results Yet
NCT01106508 | COMPLETED | PHASE1
57 Participants

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-10-31
Completion: 2015-06-30
Conditions
Advanced Solid Tumors Recurrent or Refractory Medulloblastoma Locally Advanced or Metastatic Basal Cell Carcinoma
Interventions
DRUG
No Results Yet
NCT01103986 | COMPLETED | NA
52 Participants

Assessing the Effectiveness of a Health Literacy Intervention in the Workplace

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-01-31
Completion: 2010-11-30
Conditions
Health Literacy
Interventions
BEHAVIORAL
No Results Yet
NCT01102348 | COMPLETED | NA
50 Participants

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-06-30
Completion: 2009-05-31
Conditions
Critically Ill
Interventions
OTHER
No Results Yet
NCT01051544 | WITHDRAWN | NA
0 Participants

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-09-25
Completion: 2020-06-25
Conditions
Severe Hemophilia A
Interventions
DRUG
No Results Yet
NCT01030198 | TERMINATED | NA
7 Participants

Laser Treatment for Fresh Surgical Scars and Mature Scars

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-01-31
Completion: 2010-12-31
Conditions
New Surgical Scars Scars
Interventions
DEVICE
NCT01023685 | COMPLETED | PHASE2
24 Participants

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-12-31
Completion: 2012-02-29
Conditions
Alzheimer Disease
Interventions
BIOLOGICAL
No Results Yet
NCT00981786 | COMPLETED | PHASE4
51 Participants

24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-08-31
Completion: 2010-09-30
Conditions
Glaucoma
Interventions
DRUG
No Results Yet
NCT00979810 | COMPLETED | NA
11 Participants

Image-Guided Stereotactic Biopsy of High Grade Gliomas

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-09-16
Completion: 2020-02-24
Conditions
Brain Cancer Glioma
Interventions
DRUG
NCT00894868 | COMPLETED | PHASE4
798 Participants

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-05-31
Completion: 2012-08-31
Conditions
Congestive Heart Failure Type II Diabetes Mellitus
Interventions
DRUG
No Results Yet
NCT00892203 | COMPLETED | PHASE2
75 Participants

Efficacy and Safety of BGG492 in the Treatment of Migraine

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-04-30
Completion: 2010-08-31
Conditions
Migraine
Interventions
DRUG
No Results Yet
NCT00861380 | COMPLETED | PHASE3
41188 Participants

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-05-04
Completion: 2012-01-31
Conditions
Infections, Streptococcal Streptococcus Pneumoniae
Interventions
BIOLOGICAL
NCT00844740 | WITHDRAWN | NA
0 Participants

Calcimimetics in Hypophosphatemic Rickets

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-03-01
Completion: 2012-03-01
Conditions
Familial Hypophosphatemic Rickets
Interventions
DRUG
No Results Yet
NCT00839254 | COMPLETED | PHASE3
6181 Participants

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2009-02-18
Completion: 2012-01-31
Conditions
Infections, Streptococcal Streptococcus Pneumoniae
Interventions
BIOLOGICAL
NCT00830531 | COMPLETED | PHASE1
43 Participants

Pilot Study of Bumetanide for Newborn Seizures

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-01-31
Completion: 2019-01-31
Conditions
Seizures
Interventions
DRUG
No Results Yet
NCT00821977 | COMPLETED | PHASE2/PHASE3
338 Participants

Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-11-30
Completion: 2010-10-31
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00818571 | COMPLETED | PHASE1/PHASE2
96 Participants

Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-12-31
Completion: 2009-05-31
Conditions
Renal Impairment Diabetes
Interventions
DRUG
No Results Yet
NCT00795418 | COMPLETED | PHASE2
31 Participants

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-10-31
Completion: 2010-11-30
Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL
No Results Yet
NCT00788762 | UNKNOWN
840 Participants

Myocilin Variations and Familial Glaucoma in Taxiarchis

Study Type: OBSERVATIONAL
Last Updated: 2020-12-17
Start Date: 2007-08-31
Completion: 2022-12-31
Conditions
Glaucoma
No Results Yet
NCT00777218 | WITHDRAWN | NA
0 Participants

Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2007-08-31
Completion: 2010-12-31
Conditions
Migraine
Interventions
DRUG
No Results Yet
NCT00770081 | COMPLETED | PHASE3
75 Participants

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-09-30
Completion: 2011-04-30
Conditions
Diabetes Mellitus, Type 2 Renal Insufficiency
Interventions
DRUG
No Results Yet
NCT00765830 | COMPLETED | PHASE3
349 Participants

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-09-30
Completion: 2011-04-30
Conditions
Diabetes Mellitus, Type 2 Renal Insufficiency
Interventions
DRUG
No Results Yet
NCT00757835 | COMPLETED | PHASE4
40 Participants

24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-05-31
Completion: 2009-03-31
Conditions
Glaucoma
Interventions
DRUG
No Results Yet
NCT00708292 | COMPLETED | PHASE1/PHASE2
29 Participants

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-07-31
Completion: 2011-01-31
Conditions
Relapsed or Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
NCT00670592 | COMPLETED | PHASE1/PHASE2
111 Participants

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-03-31
Completion: 2013-02-28
Conditions
Non-Hodgkin's Lymphoma Hodgkin's Lymphoma
Interventions
DRUG
No Results Yet
NCT00646542 | COMPLETED | PHASE3
525 Participants

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2005-03-31
Completion: 2010-10-31
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00633997 | TERMINATED | PHASE1/PHASE2
22 Participants

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-02-29
Completion: 2008-12-31
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00616811 | COMPLETED | PHASE3
148 Participants

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2008-01-31
Completion: 2010-10-31
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00615784 | TERMINATED | PHASE2
24 Participants

Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2010-05-25
Completion: 2013-10-01
Conditions
Acute Myeloid Leukemia
Interventions
DRUG
NCT00600275 | COMPLETED | PHASE1/PHASE2
57 Participants

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2007-12-31
Completion: 2010-03-31
Conditions
Solid Tumors Breast Cancer Cowden Syndrome
Interventions
DRUG
No Results Yet
NCT00597246 | COMPLETED | NA
30 Participants

Imaging Brain Tumors With FACBC and Methionine

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2003-05-13
Completion: 2019-11-27
Conditions
Brain Cancer CNS Cancer
Interventions
DRUG OTHER
NCT00555789 | TERMINATED | PHASE2
137 Participants

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2007-10-31
Completion: 2008-03-31
Conditions
Kidney Transplantation
Interventions
DRUG
No Results Yet
NCT00533910 | COMPLETED | NA
42 Participants

Rifaximin in Minimal Hepatic Encephalopathy

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2007-10-31
Completion: 2010-04-30
Conditions
Hepatic Encephalopathy
Interventions
DRUG
NCT00526045 | COMPLETED | PHASE1/PHASE2
117 Participants

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Study Type: INTERVENTIONAL
Last Updated: 2020-12-17
Start Date: 2007-07-31
Completion: 2012-04-30
Conditions
Breast Cancer Hematologic Neoplasms
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page